Ellipse Technologies, Inc. Completes Enrollment for the Initial Clinical Trial of the MAGEC Remote Control, Non-Invasive System for the Treatment of Scoliosis

IRVINE, Calif.--(BUSINESS WIRE)--Ellipse Technologies, Inc. (“Ellipse”) announced it had completed the initial clinical study enrollment for its MAGECTM (MAGnetic Expansion Control) Technology in “At Risk Early Onset Scoliosis Patients.”
MORE ON THIS TOPIC